Successful treatment of eruptive keratoacanthomas with actitretin for patients on checkpoint inhibitor immunotherapy-Reference-Cited by-同舟云学术

Successful treatment of eruptive keratoacanthomas with actitretin for patients on checkpoint inhibitor immunotherapy

Published:2022-01-28 Issue:6 Volume:36 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Schwartz R.J.¹²^ORCID,Ho G.¹³,Smith A.¹³,Collgros H.³⁴^ORCID,Regio Pereira A.³⁴⁵^ORCID,Gouveia B.¹,Long G.V.¹³⁶⁷,Menzies A.M.¹³⁶,Potter A.J.¹³⁸⁹,Paver E.¹³⁹,Star P.¹^ORCID,Scolyer R.A.¹³⁷⁹^ORCID,Martin L.K.¹³⁸

Affiliation:

1. Melanoma Institute Australia The University of Sydney Sydney NSW Australia

2. Department of Dermatology Faculty of Medicine University of Chile Santiago Chile

3. Faculty of Medicine and Health The University of Sydney Sydney NSW Australia

4. Sydney Melanoma Diagnostic Centre Royal Prince Alfred Hospital Sydney NSW Australia

5. Federal University of Sao Paulo Sao Paulo Brazil

6. Royal North Shore and Mater Hospitals Sydney NSW Australia

7. Charles Perkins Centre The University of Sydney Sydney NSW Australia

8. Faculty of Medicine and Health University of New South Wales Sydney NSW Australia

9. Tissue and Pathology Diagnostic Oncology Royal Prince Alfred Hospital and NSW Health Pathology Sydney NSW Australia

Publisher

Wiley